The prognostic value of p53 immunohistochemistry in gallbladder carcinoma;Der prognostische wert der p53-immunhistochemie beim gallenblasenkarzinom

Acta Chirurgica Austriaca

Volumn 33, Issue 2, 2001, Pages 85-88

  Puhalla, H ^a   Wild, T ^a   Filipits, M ^b   Wrba, F ^c   Raderer, M ^b   Krizanic, F ^a   Andonovski, A ^a   Steininger, R ^a   Muhlbacher F ^a   Langle F ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Klinischen Abteilung für Onkologie

^c Klinischen Institut für Klinische Pathologie   (Austria)

Author keywords

Gallbladder carcinoma; p53; Resection

Indexed keywords

PROTEIN P53;

ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CHOLECYSTECTOMY; CLINICAL ARTICLE; CONTROLLED STUDY; GALLBLADDER CARCINOMA; HUMAN; IMMUNOHISTOCHEMISTRY; LAPAROTOMY; PALLIATIVE THERAPY; PROGNOSIS; PROTEIN EXPRESSION; SURGICAL TECHNIQUE; TREATMENT PLANNING;

EID: 0034982774     PISSN: 0001544X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1563-2563.2001.01030.x     Document Type: Article

References (45)

1. Primary carcinoma of the gallbladder - Review of 143 cases
2. Long-term results after curative resection for carcinoma of the gallbladder
3. Analysis of failure following curative irradiation of gallbladder and extrahepatic bile duct carcinoma
4. Surgical treatment of 724 carcinomas of the gallbladder. Results of the French Surgical Association Survey
5. A biologic risk model for stage I lung cancer: Immunhistochemical analysis of 408 patients with the use of ten molecular markers
6. p53 protein immunoreactiviy in extrahepatic bile duct and gallbladder cancer: Correlation with Tumor Grade and Survival
7. Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil contious infusion with cisplatin
8. Gallbladder carcinoma: A 28 year experience
9. Molecular markers for the diagnosis and prognosis of lung cancer
10. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.)
11. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
12. Clinical implications of the p53 tumor-suppressor gene
13. Epirubicin-sequential methorexate-5-fluorouracil-leukoverin treatment in advanced cancer of the extrahepatic biliary system
14. P53 and c-erbB-2 protein expression in adenocarcinomas and epithelial dysplasias of the gallbladder
15. TP53 genotype but not immunohistochemistry is predictive for response to cisplatinium based neoadjuvant-therapy in stage III NSCLC
16. Efficiacy of 48-hour infusion of 5-fluorouracil for gall bladder cancer
17. Multidisciplinary treatment of biliary tract cancers
18. Cancer. P53, guardian of the genome
19. A death in the life of p53
20. p53 mutations, ras mutation, and p53-heat shock 70 protein complex in human lung carcinoma cell lines
21. The p53 tumor suppressor gene
22. Pilot study of ambulatory infuisonal delivery of a multidrug regimen: Cisplatin, 5-flourouracil and leucoverin (PFL) +/- etoposide
23. P53 is required for radiation-induced apoptosis in mouse thymocyzes
24. A case of advanced cholangiocellular carcinoma treated successfully by percutaneus isolated liver perfusion with cisplatin
25. The role of p53 in spontanous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice
26. Oncogenes and clinical oncology
27. DNA damage, p53 and anticancer therapies
28. Extrahepatic biliary system cancer: An update of a combined modality approach
29. Radical surgery for advanced gallbladder carcinoma
30. Aggressive surgery for carcinoma of the gallbladder
31. Cancer of the gallbladder
32. DNA strand breaks: The DNA template alterations that trigger p53-dependent DNA damage response pathways
33. Predictive value of c-erbB-2, p53, cathepsin-D, and histology of the primary tumor in metastatic breast cancer
34. Prognostic factors for adenocarcinoma of the gallbladder: An analysis of 162 cases
35. Survival after surgery for cancer of the gallbladder
36. Extended cholecystectomy for carcinoma of the gallbladder
37. P53 tumour suppressor gene protein expression in early and advanced gallbladder carcinoma
38. Molecular abnormalities in lung cancer
39. A case of unresectable advanced cancer of gallbladder successfully treated by arterial infusion therapy with cisplatin
40. Radical surgery for gallbladder carcinoma. Long-term results
41. Prospective randomized trial comparing modified FAM (5-flourouracil (5-FU) + adriamcin + mitomycin C) versus 5-FU alone for the tratment of non-resectable pancreatic and biliary tract carcinomas (the 1st trial in non-resectable patients)
42. An immunhistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinomas
43. Accumulation of p53 tumor suppressor gene protein: An independent marker of prognosis in breast cancer